
Cancer Network spoke with Daniel George, MD, of Duke Health, about the treatment landscape and current trials for renal cell carcinoma.

Your AI-Trained Oncology Knowledge Connection!


Published: June 12th 2018 | Updated:

Published: June 11th 2019 | Updated: